Showing results (121-130 of 203) with videos related to

Sort By:
Pageof 21
Cancer Research|May 15, 1987
Phase II trial of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activityJ M Leiby, K M Snider, E H Kraut, et al.
The Oncologist|May 25, 1999
A staff dialogue on caring for a cancer patient who commits suicide: psychosocial issues faced by patients, their families, and caregiversE M O'Shea, K C Lintz, R T Penson, et al.
Cancer|January 15, 1993
Age does not influence taxol dose intensity in recurrent carcinoma of the ovaryA Bicher, G Sarosy, E Kohn, et al.
Bulletin Du Cancer|January 1, 1979
Potential clinical applications of a new method for quantitation of plasma levels of 5-fluorouracil and 5-fluorodeoxyuridineR A Jones, A R Buckpitt, H H Londer, et al.
British Medical Journal|February 9, 1974
Cyclical combination chemotherapy for advanced breast carcinomaG P Canellos, V T Devita, G L Gold, et al.
The Oncologist|November 7, 1999
A staff dialogue on a socially distanced patient: psychosocial issues faced by patients, their families, and caregiversA Goodman, R T Penson, R Blatman, et al.
The Oncologist|March 8, 2000
Sedation for intractable distress of a dying patient: acute palliative care and the principle of double effectE L Krakauer, R T Penson, R D Truog, et al.
Blood|June 1, 1976
Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapyG P Canellos, V T DeVita, J Whang-Peng, et al.
Cancer|November 1, 1978
Hexamethylmelamine in alkylating agent-resistant ovarian carcinomaB L Johnson, R I Fisher, R A Bender, et al.
Annals of Internal Medicine|April 1, 1976
Combination chemotherapy for advanced breast cancer: response and effect on survivalG P Canellos, V T DeVita, G L Gold, et al.
Pageof 21